Procurement Summary
Country: Brazil
Summary: The Object of this Bidding Process is the Selection of a Company to Register Prices for Future Acquisitions and Possible Introduction of Insulin Ii Analogue Medicines and Others, to Meet Demand...
Deadline: 26 Jun 2026
Posting Date: 15 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143326219
Document Ref. No.: 90161/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - The object of this bidding process is the selection of a company to register prices for future acquisitions and eventual release of insulin ii analogue medicines and others, to meet the demand of the municipal secretariat of Saúde de Fortaleza SMS, in accordance with the specifications and quantities set out in the annex to the terms of reference of this notice. UASG code: 927744 Notice from: 06/15/2026 from 08:00 to 12:00 and from 12:01 to 17:00 Proposal Delivery: from from 06/15/2026 to 08:00 INSULIN, LISPRO TYPE, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATOR Quantity: 110 SEMAGLUTIDE, CONCENTRATION 1.34 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, CHARACTERISTICS ADDITIONS WITH APPLICATION SYSTEM Quantity: 98 SEMAGLUTIDE, CONCENTRATION 1.34 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 32 INSULIN, ASPART ORIGIN, CONCENTRATION 100 IU/ML, FORM PHARMACEUTICA INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATOR Quantity: 173 LIRAGLUTIDE, CONCENTRATION 6 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 IN FILLED APPLICATOR PEN Quantity: 2138 LIRAGLUTIDE, CONCENTRATION 6 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 IN FILLED APPLICATOR PEN Quantity: 712
Documents
Tender Notice